New imaging tool helps doctors see brain tumors more clearly
NCT ID NCT05511714
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This program offers a special PET scan using a radioactive tracer called methionine to help doctors better see and manage central nervous system (brain, spine) and head/neck tumors in children and young adults. The scan provides extra information that can guide treatment decisions. Anyone under care at St. Jude with known or suspected tumors in these areas can participate, with no age limit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
AVAILABLEMemphis, Tennessee, 38105, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One drop, many cancers? a rapid test aims to spot cancer signals in blood, urine, or saliva
- Touch and tingle: Non-Drug therapies aim to tame chemo side effects
- Glowing dye could help surgeons spot hidden brain tumor cells
- Engineered immune cells target deadly brain tumors in children
- New tool aims to ease the journey for head and neck cancer survivors and caregivers
- New drug targets hard-to-treat cancers in early trial